AI documentation for haematology and oncology
Tumour board minutes, treatment plan and letter drafted from the consultation. You review, Nixi AI writes the draft.
Fictional people, AI-generated.
Made for tumour boards
and the course of treatment.
01 / 04
Conversation
From the consultation to structured documentation
Nixi AI listens and sorts history, staging and treatment decision into your structure. You review the draft before it goes into the record.
Structured noteLive · 18:24Mrs Becker · 52 · first diagnosis 03/2026Tumour board minutes · breast cancer
Case presentationFirst diagnosis of right breast cancer, upper outer quadrant, 18 mm. CT chest/abdomen without distant metastases. Axilla unremarkable on ultrasound.
Histology (core biopsy) + receptorsInvasive ductal G2. ER 95 % · PR 80 % · HER2 negative · Ki-67 18 %. Luminal B-like.
TNM staging · cT1c cN0 cM0UICC stage I · low to intermediate risk (Oncotype DX requested).
Tumour board decisionBreast-conserving surgery · adjuvant radiotherapy · endocrine therapy 5 years · chemotherapy depending on recurrence score.
Draft02 / 04
Letter
Tumour board minutes and letter from one conversation
TNM, histology, line of therapy and next steps sit in the letter where they belong. Drafted from the conversation, released by you.
Letter to the GPDraftDiagnosisInvasive ductal carcinoma of the right breast, upper outer quadrant, 18 mm, cT1c cN0 cM0, UICC stage I (C50.4, right).
Histology (core biopsy)G2, ER 95 %, PR 80 %, HER2 negative, Ki-67 18 %, luminal B-like. Axilla unremarkable on ultrasound, CT chest/abdomen without distant metastases.
Tumour board recommendationBreast-conserving surgery, adjuvant radiotherapy, endocrine therapy for 5 years. Chemotherapy depending on the recurrence score (Oncotype DX requested).
03 / 04
Codes
ICD-10-GM as suggestions for review
Nixi AI suggests matching C and D codes from the documentation. You confirm; billing stays with you.
ICD-10-GM suggestionsSuggestions to review- C50.4Malignant neoplasm: upper-outer quadrant of breast, rightRight breast cancer, upper outer quadrant
04 / 04
Practice system
Into your record, by copy or interface
The released text lands in Medistar, medatixx, tomedo or your system. Copying on every plan, the direct interface as an add-on to the annual plan.
Mrs Becker · 52 · first diagnosis 03/2026 · Practice system · recordANABEFTHEDIAGePALABREZÜBW28.04.26 DiANAFirst diagnosis of right breast cancer, upper outer quadrant, 18 mm. CT chest/abdomen without distant metastases. Axilla unremarkable on ultrasound.28.04.26 DiBEFInvasive ductal G2. ER 95 % · PR 80 % · HER2 negative · Ki-67 18 %. Luminal B-like.28.04.26 DiDIAGC50.428.04.26 DiTHEBreast-conserving surgery · adjuvant radiotherapy · endocrine therapy 5 years · chemotherapy depending on recurrence score.CGM Medistar + CGM ONKOSTARCGM Turbomedmedatixxtomedo
Frequently asked
Your questions about Nixi AI in haematology and oncology.
Yes. Nixi AI drafts oncology letters, tumour board minutes, treatment plans and progress notes from the consultation. Reduced documentation time in 82 % of cases in the EULAR 2025 study (measured in rheumatology; transferability not examined). Nixi AI understands TNM staging, treatment regimens and ICD-10/ICD-O coding. GDPR-compliant on GDPR-compliant cloud infrastructure.
Yes. Nixi AI can listen in on interdisciplinary tumour boards and draft structured minutes: participants, cases presented, TNM, treatment recommendation and guideline reference.
Nixi AI drafts the clinical letter. Transfer into tumour documentation systems such as ONKOSTAR happens through the practice system (CGM Medistar, Turbomed, medatixx, tomedo). Practice Pro supports all common practice systems.
Yes. Storage in Frankfurt, processing in the EU and Switzerland. Medical confidentiality (§ 203 StGB) is preserved. Genetic data (BRCA, molecular pathology) is processed as especially sensitive health data.
Especially there. The more complex the letter, the more structure Nixi AI takes over: a multi-page first oncology letter is drafted from the conversation for the physician to review and release, instead of being written from scratch. Time measurements come from rheumatology (EULAR 2025); there are no separate measurements for oncology.
Yes. Nixi AI drafts oncology letters, tumour board minutes, treatment plans and progress notes from the consultation. Reduced documentation time in 82 % of cases in the EULAR 2025 study (measured in rheumatology; transferability not examined). Nixi AI understands TNM staging, treatment regimens and ICD-10/ICD-O coding. GDPR-compliant on GDPR-compliant cloud infrastructure.
Yes. Nixi AI can listen in on interdisciplinary tumour boards and draft structured minutes: participants, cases presented, TNM, treatment recommendation and guideline reference.
Nixi AI drafts the clinical letter. Transfer into tumour documentation systems such as ONKOSTAR happens through the practice system (CGM Medistar, Turbomed, medatixx, tomedo). Practice Pro supports all common practice systems.
Yes. Storage in Frankfurt, processing in the EU and Switzerland. Medical confidentiality (§ 203 StGB) is preserved. Genetic data (BRCA, molecular pathology) is processed as especially sensitive health data.
Especially there. The more complex the letter, the more structure Nixi AI takes over: a multi-page first oncology letter is drafted from the conversation for the physician to review and release, instead of being written from scratch. Time measurements come from rheumatology (EULAR 2025); there are no separate measurements for oncology.
Get to know Nixi AI through an oncology case.
Try it yourself, or let us show you in 30 minutes.
In German or English.